STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionMay 8, 2026, 04:12 PM

Quantum Cyber Increases Equity Offering to $100M

AI Summary

Quantum Cyber N.V. amended its Equity Distribution Agreement with Maxim Group LLC, significantly increasing the aggregate offering amount of its ordinary shares from $10 million to $100 million. This amendment provides the company with greater flexibility for capital raising. Additionally, the company entered into a Consulting Agreement with its Chief Financial Officer, William Caragol, effective April 22, 2026, for financial and accounting services, with a monthly retainer of $20,000 and potential equity grants.

Key Highlights

  • Equity distribution agreement with Maxim Group LLC increased from $10,000,000 to $100,000,000.
  • The offering is for ordinary shares with a nominal value of €0.01 per share.
  • Company entered into a Consulting Agreement with CFO William Caragol, effective April 22, 2026.
  • Mr. Caragol will provide financial and accounting services.
  • Monthly retainer for Mr. Caragol is $20,000.
  • Mr. Caragol may receive stock or option grants from the 2025 Omnibus Stock Plan.
  • Consulting term is from April 22, 2026, to August 31, 2026, with monthly extension option.
QUCY
Biotechnology: Pharmaceutical Preparations
MAINZ BIOMED N.V.

Price Impact